Market Analysis - Euro Psychiatry 2020
The global psychiatrist’s market was valued at $795.1 billion in 2017. North America was the largest geographic region accounting for $380.1 billion or 47.8% of the global market. The USA was the largest country accounting for $318.8 billion or 40% of the global psychiatrist’s market.
The global market for antipsychotic drugs was worth $80.5 billion in 2010 and that value is worth to be $88.3 billion in 2015. The global Behavioral health software market in 2014 is $0.75 billion and is expected to reach $1.5 billion by 2020.
According to BBC research the global market for drugs treating mental disorders was valued as $70.1 billion in 2012 and is estimated to have declined slightly to nearly $69 billion in 2013 and by 2018 it aims the market growth approximately to $77.1 billion.
Rise in stress condition, emotional and psychological pressure increases the demand for psychiatric therapies and antipsychotic drugs. According to WHO, 350 million population is suffering from psychiatric disorders and depression. Also around 24 million of the population is diagnosed with Schizophrenia. Thus skyrocketing the demand and market growth. Following table shows the antipsychotic drug count prescribed by psychologists.
Digital psychotherapy is a major trend in psychiatrists’ market. The digital age has entered in the area of psychotherapy. This is called digital psychotherapy. Digital psychotherapy enables people with disabilities and people in remote areas to have access to therapy and education of their problems. Some counselors are already using this technology to hold therapy sessions.
Psychiatrists Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global psychiatrists market.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
It places the market within the context of the wider healthcare market and compares it with other markets.
• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market segmentations break down market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
• The psychiatrists market section of the report gives context. It compares the psychiatrists market with other segments of the psychiatrists market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Psychiatrists Market Indicators Comparison.
Importance & Scope: According to WHO, Psychiatry is defined as a state of well-being in which every individual realizes his or her own potential and can cope with the normal stresses of life, work productively and fruitfully, and are able to contribute to his or her community. Psychological Syndrome is the health condition that is characterized by alterations in thinking, mood, and behavior that is associated with distress or impaired functioning. Mental disorders contribute to problems that may include disability, pain, or death.
Globally, depression affects about 400 million, dementia affects about 35 million, while Schizophrenia which affects about 21 million people. Unipolar (also known as Major) depressive disorder is the third leading cause of disability worldwide, of any condition mental or physical, accounting for 65.5 million years lost. Overall list, responsible for 23.7 million DALYs globally, while other drug-use disorders accounted for 8.4 million. Schizophrenia causes a total loss of 16.8 million DALY, and bipolar disorder 14.4 million. Panic disorder leads to 7 million years lost, obsessive-compulsive disorder 5.1, primary insomnia 3.6, and post-traumatic stress disorder 3.5 million daily. Over one’s entire lifetime, the average American has a 47.4 percent chance of having any kind of mental health disorder. It has been reported that, in Germany, depression is ten times more frequent.
6. Health care professionals
8. Industrial Experts
10. Mental health Nurses
12. Nutritional Scientists
13. Lecturers and Students from Academia
14. Students from Academia in the research of Psychology
1. Eli Lilly
2. AstraZeneca GlaxoSmithKline
5. Universal Health Services Inc.
6. Astellas Pharma Inc.
7. Johnson & Johnson
8. Bristol-Meyer Squibb
Related Associations and Societies:
1. Afghanistan National Psychiatrist Association
2. Albanian Psychiatric Association
3. American Psychiatric Association
4. Austrian Association for Psychiatry and Psychotherapy
5. Indian Psychiatric Society
6. Independent Psychiatric Association of Russia
7. Spanish Society of Psychiatry
8. Swedish Psychiatric Association
Yemen Psychiatrists & Neurologists Association